Skip to content
TrialScanner

NCT06342947

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Phase 2CompletedALGSLead

Registry record

Lead sponsor
Aligos Therapeutics
Conditions
NASH; MASH; Metabolic Dysfunction-Associated Steatohepatitis; Nonalcoholic Steatohepatitis
Primary completion
Aug 19, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06342947 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06342947: ALG-055009 in Non-cirrhotic... | TrialScanner